Literature DB >> 29397935

The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Khosrow Kashfi1.   

Abstract

Nitric oxide (NO) a gaseous free radical is one of the ten smallest molecules found in nature, while hydrogen sulfide (H2S) is a gas that bears the pungent smell of rotten eggs. Both are toxic yet they are gasotransmitters of physiological relevance. There appears to be an uncanny resemblance between the general actions of these two gasotransmitters in health and disease. The role of NO and H2S in cancer has been quite perplexing, as both tumor promotion and inflammatory activities as well as anti-tumor and antiinflammatory properties have been described. These paradoxes have been explained for both gasotransmitters in terms of each having a dual or biphasic effect that is dependent on the local flux of each gas. In this review/commentary, I have discussed the major roles of NO and H2S in carcinogenesis, evaluating their dual nature, focusing on the enzymes that contribute to this paradox and evaluate the pros and cons of inhibiting or inducing each of these enzymes.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CBS; CSE; Carcinogenesis; Hydrogen sulfide; Nitric oxide; iNOS

Mesh:

Substances:

Year:  2018        PMID: 29397935      PMCID: PMC5866221          DOI: 10.1016/j.bcp.2018.01.042

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  348 in total

1.  Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?

Authors:  Rui Wang
Journal:  FASEB J       Date:  2002-11       Impact factor: 5.191

2.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

3.  Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma.

Authors:  S H Juang; K Xie; L Xu; Y Wang; J Yoneda; I J Fidler
Journal:  Cancer Biother Radiopharm       Date:  1997-06       Impact factor: 3.099

4.  Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats.

Authors:  S Tamano; J M Ward; B A Diwan; L K Keefer; C M Weghorst; R J Calvert; J R Henneman; D Ramljak; J M Rice
Journal:  Carcinogenesis       Date:  1996-11       Impact factor: 4.944

5.  Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse.

Authors:  Ling Li; Madhav Bhatia; Yi Zhun Zhu; Yi Chun Zhu; Raina Devi Ramnath; Zhong Jing Wang; Farhana Binte Mohammed Anuar; Matthew Whiteman; Manuel Salto-Tellez; Philip K Moore
Journal:  FASEB J       Date:  2005-04-29       Impact factor: 5.191

Review 6.  The potential role of the red blood cell in nitrite-dependent regulation of blood flow.

Authors:  Rakesh P Patel; Neil Hogg; Daniel B Kim-Shapiro
Journal:  Cardiovasc Res       Date:  2010-10-14       Impact factor: 10.787

7.  Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.

Authors:  Wagdi Elsheikh; Rory W Blackler; Kyle L Flannigan; John L Wallace
Journal:  Nitric Oxide       Date:  2014-04-18       Impact factor: 4.427

8.  Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function.

Authors:  Li-Fang Hu; Ming Lu; Zhi-Yuan Wu; Peter T-H Wong; Jin-Song Bian
Journal:  Mol Pharmacol       Date:  2008-10-02       Impact factor: 4.436

9.  Production of hydrogen sulfide from d-cysteine and its therapeutic potential.

Authors:  Norihiro Shibuya; Hideo Kimura
Journal:  Front Endocrinol (Lausanne)       Date:  2013-07-16       Impact factor: 5.555

10.  Polysulfides (H2Sn) produced from the interaction of hydrogen sulfide (H2S) and nitric oxide (NO) activate TRPA1 channels.

Authors:  Ryo Miyamoto; Shin Koike; Yoko Takano; Norihiro Shibuya; Yuka Kimura; Kenjiro Hanaoka; Yasuteru Urano; Yuki Ogasawara; Hideo Kimura
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

View more
  11 in total

1.  The vasodilatory mechanism of nitric oxide and hydrogen sulfide in the human mesenteric artery in patients with colorectal cancer.

Authors:  Awat Y Hassan; Ismail M Maulood; Abbas Salihi
Journal:  Exp Ther Med       Date:  2021-01-15       Impact factor: 2.447

Review 2.  Targeted contrast agents and activatable probes for photoacoustic imaging of cancer.

Authors:  Zhenxiang Zhao; Chelsea B Swartchick; Jefferson Chan
Journal:  Chem Soc Rev       Date:  2022-02-07       Impact factor: 60.615

Review 3.  The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.

Authors:  Kearsley M Dillon; Ryan J Carrazzone; John B Matson; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-03-26       Impact factor: 5.858

Review 4.  Molecular targets of statins and their potential side effects: Not all the glitter is gold.

Authors:  Kush K Patel; Viren S Sehgal; Khosrow Kashfi
Journal:  Eur J Pharmacol       Date:  2022-03-20       Impact factor: 4.432

5.  Amino acid-based H2S donors: N-thiocarboxyanhydrides that release H2S with innocuous byproducts.

Authors:  Kuljeet Kaur; Patrick Enders; Yumeng Zhu; Abigail F Bratton; Chadwick R Powell; Khosrow Kashfi; John B Matson
Journal:  Chem Commun (Camb)       Date:  2021-06-03       Impact factor: 6.065

6.  Protective effects of asiaticoside on renal ischemia reperfusion injury in vivo and in vitro.

Authors:  Shengjie Tang; Xiangcheng Xie; Ming Wang; Lili Yang; Wei Wei
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 7.  S-nitrosothiols and H2S donors: Potential chemo-therapeutic agents in cancer.

Authors:  Adriana Karla Cardoso Amorim Reis; Arnold Stern; Hugo Pequeno Monteiro
Journal:  Redox Biol       Date:  2019-04-05       Impact factor: 11.799

8.  In vitro anticancer activity of hydrogen sulfide and nitric oxide alongside nickel nanoparticle and novel mutations in their genes in CRC patients.

Authors:  Zjwan Housein; Tayeb Sabir Kareem; Abbas Salihi
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

Review 9.  Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells.

Authors:  Csaba Szabo
Journal:  Cells       Date:  2021-01-22       Impact factor: 6.600

Review 10.  Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO.

Authors:  Khosrow Kashfi; Jasmine Kannikal; Niharika Nath
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.